Historical record - last NADAC effective date: 4/19/2023
Product Information
OXYMORPHONE HCL 5 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.5201 per EA under NDC 31722092901. Its NADAC has been published 304 times since Jun 20, 2018.
FDA first approved this application on Feb 2, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722092901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/19/2023
Active Ingredients
OXYMORPHONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210175FDA Approved
2/2/2018
TE Code
AB
On Market Since
3/1/2018
Pharmacological Classes
Price Statistics
The NADAC for OXYMORPHONE HCL 5 MG TABLET has been published 304 times since Jun 20, 2018, and over the history we have for it it has declined 39.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5201 per EA |
|---|---|
| All-time high | $1.0303 (May 15, 2019) |
| All-time low | $0.3420 (Sep 23, 2020) |
| Median price | $0.5629 |
| Average price | $0.6106 |
| Largest weekly change | +123.9% (Dec 23, 2020) |
| Weeks tracked | 304 |
| Tracking since | Jun 20, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
0.0%
5Y
+38.3%
All
-39.5%
Last surveyed Apr 10, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the OXYMORPHONE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
OXYMORPHONE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OXYMORPHONE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYMORPHONE HCL 5 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.5201 per EA (NDC 31722092901), effective Apr 10, 2024.
How has the price of OXYMORPHONE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYMORPHONE HCL 5 MG TABLET has declined 39.5%. It has been tracked across 304 weekly CMS publications since Jun 20, 2018.
What are the highest and lowest recorded NADAC prices for OXYMORPHONE HCL 5 MG TABLET?
Since Jun 20, 2018, the NADAC for OXYMORPHONE HCL 5 MG TABLET has ranged from a low of $0.3420 (Sep 23, 2020) to a high of $1.0303 (May 15, 2019), with a median of $0.5629 per EA.
Are there cheaper alternatives to OXYMORPHONE HCL 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of OXYMORPHONE HCL 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OXYMORPHONE HCL 5 MG TABLET?
OXYMORPHONE HCL 5 MG TABLET (NDC 31722092901) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.